tirzepatide & semaglutide Fridays | GLP-1 Telehealth Overview of Tirzepatide and Semaglutide

The short-term cost-effectiveness of once-weekly semaglutide versus once-daily sitagliptin and once-weekly dulaglutide for the treatment of patients with type 2 diabetes: a cost of control analysis in Spain

The key difference between these medications lies in their active ingredients

372,373 In neoadjuvant endocrine therapy of HR+/HER2 breast cancer, achieving pCR is not the primary goal, therefore studies such as NeoMONARCH and PALLET focus on changes in Ki67 levels and complete cell cycle arrest with the addition of CDK4/6 inhibitors

Activated neutrophils can efficiently recognize and uptake these nanomedicines that have been complement-processed, thereby targeting them to the liver inflammation sites